Clinical Trial Update: A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-031/LIGHTRAY EXTENSION) [Phase 2]

View source ↗

Summary

Phase 2 clinical study update for sotatercept (MK-7962) in pulmonary arterial hypertension; the LIGHTRAY EXTENSION study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Sotatercept (sotatercept)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Pulmonary Arterial Hypertension | Phase 2 | Status: ACTIVE_NOT_RECRUITING